Mayo Clinic News Network

News Resources

Dana Sparks (@danasparks) published a blog post · September 24th, 2013

Drug Fails to Reduce Diarrhea in Patients Receiving Radiation Therapy

Sulfasalazine, a drug commonly prescribed to reduce diarrhea in patients with inflammatory bowel disease, does not reduce diarrhea in patients receiving radiation therapy for cancers in the pelvic area. The Mayo Clinic-led study also found that the medication may be associated with a higher risk of diarrhea than a placebo when used during radiation therapy to the pelvis. Robert Miller, M.D., a radiation oncologist and the study's lead author, says, “Patients receiving radiation therapy in the pelvic region can experience diarrhea which is a negative side effect of the therapy.”

The results are being presented at the American Society of Radiation Oncology’s (ASTRO’s) Meeting in Atlanta.

Read news release.

Journalists: Sound bites with Dr. Miller are available in the downloads.

cancer diarrhea Dr. Robert Miller Inflammatory Bowel Disease oncology pelvic area radiation


Have something to say? Please login or register to respond.